Amarin Corp. (AMRN) Tops Q4 EPS by 4c, Revs Beat; Reaffirms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Amarin Reports Record Fourth Quarter and Full Year 2019 Financial Results and Provides Update on Operations
February 25, 2020 4:06 PM ESTRecord Revenue of $429.8 Million and $143.3 Million for Full Year and Fourth Quarter 2019Â Â
Launch Commenced of VASCEPA® as First and Only Drug with Its New Cardiovascular Risk Reduction Indication
Management to Host Conference Call at 4:30 p.m. ET Today
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced financial results for the quarter and year ended December 31, 2019 and provided an update on company operations.
Key Amarin recent achievements... More
